Rune Labs
PrivateLast Round
Series A
Extension
Jan 11, 2024
Total Funding Raised
$42.1M
Company Overview
Rune Labs is a healthcare technology company that provides a software and data analytics platform for precision neurology to support care delivery and therapy development.
Sector
Healthcare & Life Sciences
Verticals
Healthcare Analytics, Precision Medicine, Clinical Trials, Medical AI
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rune Labs Comparables
Compare Rune Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuroRPM | 91% | |
| h2o Therapeutics | 80% | |
| Great Lakes NeuroTechnologies Inc. | 79% |
Rune Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 11, 2024 | ||||
| Series A | Sep 16, 2021 | ||||
| Seed | Oct 26, 2020 | ||||
| Pre Seed | Sep 3, 2019 |
Rune Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| DigiTx Partners | Series A, Series A Extension, Seed |
| Moment Ventures | Series A, Series A Extension, Pre Seed, Seed |
| TruVenturo | Series A Extension, Pre Seed, Seed |
| Nexus NeuroTech Ventures | Series A Extension |
| Eclipse Ventures | Series A Extension, Series A |
| Deepwater Asset Management | Pre Seed, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 15, 2026
Launched an AI platform for continuous Parkinson's disease symptom tracking.
- Oct 21, 2025
Adam Pellegrini appointed as independent board member.
Rune Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Rune Labs's valuation, stock price, and market status.
Is Rune Labs a public or private company?
Rune Labs is a private company.
What is the current stock price of Rune Labs?
Rune Labs is a private company with no public stock price. No recent secondary market data is available.
How much is Rune Labs worth (valuation)?
Valuation information for Rune Labs is not publicly available.
Can I buy Rune Labs stock?
Rune Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Rune Labs's last funding round?
Rune Labs's most recent funding round was Strategic on January 11, 2024.
Who are the main investors in Rune Labs?
Key investors in Rune Labs include DigiTx Partners, Nexus NeuroTech Ventures.
Will Rune Labs IPO soon?
No public IPO plans have been announced for Rune Labs.
How can I track Rune Labs secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Rune Labs's secondary market activity and sign up for updates.